PDE5 inhibitors blunt inflammation in Benign Prostatic Hyperplasia (BPH): A potential mechanism of action for PDE5 inhibitors in Low Urinary Tract Symptoms (LUTS)

被引：0
|
作者：
Santi, R. [1 ]
Vignozzi, L. [1 ]
Gacci, M. [1 ]
Pepi, M. [1 ]
Baroni, G. [1 ]
Carini, M. [1 ]
Maggi, M. [1 ]
Nesi, G. [1 ]
机构：
[1] Univ Florence, I-50121 Florence, Italy
来源：
VIRCHOWS ARCHIV | 2013年 / 463卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：349 / 349
页数：1
相关论文
共 50 条
  • [41] Testosterone and PDE5 Inhibitors Non Responders
    Schulman, C.
    Destraix, R.
    Roumeguere, T.
    JOURNAL OF SEXUAL MEDICINE, 2004, 1 : 57 - 57
  • [42] PDE5 inhibitors beyond erectile dysfunction
    Sandner, P.
    Huetter, J.
    Tinel, H.
    Ziegelbauer, K.
    Bischoff, E.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (06) : 533 - 543
  • [43] PDE5 inhibitors not associated with malignant melanoma
    Reactions Weekly, 2016, 1608 (1) : 8 - 8
  • [44] PDE5 inhibitors and permanent visual loss
    R Tomsak
    International Journal of Impotence Research, 2005, 17 : 547 - 549
  • [45] Inhibitors of PDE1 and PDE5 cGMP phosphodiesterases: Patents and therapeutic potential
    Sybertz, E
    Czarniecki, M
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (06) : 631 - 639
  • [46] PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells
    Sponziello, Marialuisa
    Verrienti, Antonella
    Rosignolo, Francesca
    De Rose, Roberta Francesca
    Pecce, Valeria
    Maggisano, Valentina
    Durante, Cosimo
    Bulotta, Stefania
    Damante, Giuseppe
    Giacomelli, Laura
    Gioia, Cira Rosaria Tiziana Di
    Filetti, Sebastiano
    Russo, Diego
    Celano, Marilena
    ENDOCRINE, 2015, 50 (02) : 434 - 441
  • [47] Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach
    Ongaro, Alberto
    Zagotto, Giuseppe
    Memo, Maurizio
    Gianoncelli, Alessandra
    Ribaudo, Giovanni
    NATURAL PRODUCT RESEARCH, 2021, 35 (10) : 1648 - 1653
  • [48] PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells
    Marialuisa Sponziello
    Antonella Verrienti
    Francesca Rosignolo
    Roberta Francesca De Rose
    Valeria Pecce
    Valentina Maggisano
    Cosimo Durante
    Stefania Bulotta
    Giuseppe Damante
    Laura Giacomelli
    Cira Rosaria Tiziana Di Gioia
    Sebastiano Filetti
    Diego Russo
    Marilena Celano
    Endocrine, 2015, 50 : 434 - 441
  • [49] Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED
    Boyle, CD
    Xu, R
    Asberom, T
    Chackalamannil, S
    Clader, JW
    Greenlee, WJ
    Guzik, H
    Hu, YQ
    Hu, ZY
    Lankin, CM
    Pissarnitski, DA
    Stamford, AW
    Wang, YG
    Skell, J
    Kurowski, S
    Vemulapalli, S
    Palamanda, J
    Chintala, M
    Wu, P
    Myers, J
    Wang, P
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (09) : 2365 - 2369
  • [50] PDE5 inhibitors: targeting erectile dysfunction in diabetics
    Francis, Sharron H.
    Corbin, Jackie D.
    CURRENT OPINION IN PHARMACOLOGY, 2011, 11 (06) : 683 - 688
12345